Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma.

R Aldeghi; P Lissoni; S Barni; A Ardizzoia; G Tancini; A Piperno; M Pozzi; G Ricci; A Conti; G J Maestroni

doi:10.1016/0959-8049(94)90080-9

Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma.

Identifier:nobleid.org/w1/20260515/C8CFFAF1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C8CFFAF1.svg?ark=w1%2F20260515%2FC8CFFAF1)](https://nobleid.org/work/w1/20260515/C8CFFAF1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma.

Identifier:nobleid.org/w1/20260515/C8CFFAF1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C8CFFAF1.svg?ark=w1%2F20260515%2FC8CFFAF1)](https://nobleid.org/work/w1/20260515/C8CFFAF1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work